Penumbra Secures U.S. Clearance for Thunderbolt CAVT Technology

Penumbra announced that its Thunderbolt CAVT technology has obtained clearance in the United States. The clearance was confirmed by NeuroNews International. Thunderbolt CAVT is a technology developed by Penumbra. The approval allows the company to market the technology in the U.S. Penumbra expects the clearance to open new commercial opportunities. The company highlighted the regulatory milestone as a key achievement. Details on the specific regulatory body were not disclosed in the report. Penumbra plans to advance the technology’s deployment following the clearance.